Pharma Patient Access

Patient Adherence & Access Insights Solutions

It is crucial that we instrument the entire patient journey so we can understand what, if any, obstacles they’re encountering.”

Vice President | Market Access

Turbocharge Your Specialty Pharmacy Network

Use data to identify patient journey obstacles and develop patient initiation and patient adherence solutions.

Obstacles Impacting the Pharma to Patient Journey

  • Obtaining patient journey status updates in a timely manner
  • Ensuring patient data is mastered in a consistent, accurate manner
  • Collaborating with specialty pharmacy partners to efficiently share patient data
Turbocharge Specialty Pharmacy Network
Improve Patient Initiation

Improve Patient Initiation

With accurate, real-time patient data, manufacturers better understand the barriers affecting patient initiation.

Industry research shows that 30% to 50% of scripts never get filled. Manufacturers can gain insights into payer, channel, and provider-related obstacles impacting the pharma patient journey by properly leveraging patient status data.

Track Patient Adherence

Even once the patient initiates therapy, adherence is hardly guaranteed. Ongoing payer issues, out-of-pocket costs, and side effects are a few of the factors that complicate the patient journey.

In fact, the National Institute of Health data shows that adherence rates for most medications for chronic conditions such as diabetes and hypertension usually fall in the 50% to 60% range, even with patients who have good insurance and drug benefits. To combat this, pharmaceutical manufacturers often throw money into an array of patient services programs, but without accurate patient status and dispensing data, these programs can be a huge investment with little return.

Drug manufacturers can develop effective patient adherence solutions by:

  • Having access to quality patient status data that is readily available
  • Collaborating across channels to accurately measure the impact of pharma to patient access service programs on patient adherence
  • Quickly and correctly identifying friction points between pharmacies and patient services
Track Patient Adherance

Gain Reliable Pharma Patient Journey Insights in Real-Time

Pharmaceutical manufacturers need access to reliable, consistent, and timely patient data in order to make business decisions that affect their bottom line. Whether you’re an existing manufacturer trying to identify breakdowns in patient adherence or you’re an emerging manufacturer trying to get a handle on co-pay program costs, IntegriChain can turn mountains of patient access data into actionable insights for your pharma market access teams.

Every specialty pharmaceutical manufacturer needs answers to a common set of critical business questions around patient initiation and patient adherence:

  • Has the patient started therapy?
  • Does the patient understand how to properly administer the drug?
  • Did the patient encounter issues with prior authorization requirements?
  • Is the patient unable to afford the treatment?
  • Did the patient refill the prescription as planned, or have they discontinued therapy?
  • Has patient outreach and support been performed per the contract?

Unfortunately, manufacturers often realize each specialty pharmacy has its own ways of calculating metrics and statuses. They also frequently uncover:

  • Missing patient status updates
  • Missing payer data
  • Confusing or out-of-sequence patient status reports
  • Issues with patient data mastering

These issues often prevent manufacturers from getting a clear, consistent line of sight into the pharma patient journey, including medication access and adherence. IntegriChain understands how to amplify the manufacturer-specialty pharmacy relationship and make the patient status the central point of efficient, data-driven collaboration.

Interested in learning more?

Improve your pharma patient access process

Case Study

Unleashing Machine Learning to Improve Patient Intervention Effectiveness

Learn how IntegriChain applied machine learning and data science to help a major pharmaceutical manufacturer gain deep insight into the timing, cost, and effectiveness of patient intervention programs.

Read the Case Study


Best Practices: Identifying and Avoiding Patient Access Barriers

Market Access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.

Read more

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article